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A 61-year-old man presented to our hospital with right eye pain and headache off and on for 1 month. He
had twice trabeculectomy in the right eye 25 years ago without using antiglaucoma agents. Snellen visual
acuity (VA) was 20/400 and intraocular pressure (IOP) was 52 mm Hg in his right eye. The slit-lamp
examination of his right eye revealed corneal microcystic edema and two blebs were noted. The nasal
upper bleb had thinner wall with obvious focal underlying uvea dark color and temporal upper bleb had
relative thicker wall. Both blebs showed low lying and high vascularity. No pupillary block was present.
Considering the risks of repeat trabeculectomy and drainage implant, needle revision was done on the
temporal upper bleb.
A mixture of lidocaine and mitomycin C (MMC) was prepared for a ﬁnal MMC concentration of
0.07 mg/ml. After 15 minutes of subconjunctival injection of lidocaine-MMC mixture, the needle revision
was done to disrupt any episcleral and scleral ﬁbrosis. Restoration of aqueous drainage was considered to
be the end point when the bleb height was restored. The right eye VA was 20/100 on postoperatively Day
1 and IOP was 8 mm Hg. The only minor complication was subconjunctival hemorrhage. The IOP was
around 10-15 mm Hg without antiglaucoma agent during a 6-month follow-up. The temporal upper bleb
remained moderate height without hypervascularity or cystic change and no corneal edema was noted.
Bleb needling with adjunctive MMC is simple and safe. It should be considered in the management of
failing or failed ﬁltration blebs.
Copyright  2012, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
While trabeculectomy with adjunctive antiﬁbrotic agents has
been the standard surgical treatment for glaucoma, subconjunctival
or episcleral ﬁbrosis leading to late bleb failure is still unavoidable.
When a late ﬁltering surgery fails and intraocular pressure (IOP) is
not controlled by the topical antiglaucoma agents, surgery is
usually needed. The surgical options include revision of the existing
ﬁlter, repeat trabeculectomy, drainage implant surgery, or a cyclo-
destructive procedure. Each of these options has their own
advantages and disadvantages. Needle revision of the failing
ﬁltration bleb with concurrent antimetabolite like 5-ﬂuorouracil (5
- FU)1e4 or mitomycin C(MMC)5e8 has been shown as an effective
and simple way of reestablishing aqueous ﬂow and lowering the
IOP. It can decrease surgical risks in patients after multiple trabe-
culectomies.We presented a case after twice trabeculectomy withthalmology, National Taiwan
e Ophthalmologic Society of Taiwlate bleb failure after 25 years and needle revision with MMC
successfully saved the bleb and restored its function.2. Case report
A 61-year-old man presented to our hospital with right eye pain
and headache off and on for 1 month. He had twice trabeculectomy
in the right eye 25 years ago. He had no antiglaucoma agents during
these 20 years. Bilateral shallow anterior chamber with patent laser
peripheral iridotomy (LPI) was noted in his both eyes. Snellen visual
acuity (VA) was 20/400 and IOP was 52 mm Hg in his right eye. VA
was 20/25 and IOP was 16 mm Hg in the left eye. The slit-lamp
examination of his right eye revealed corneal microcystic edema
and two blebs were noted. The nasal upper bleb had thinner wall
with obvious focal underlying uvea dark color and temporal upper
bleb had relative thicker wall. Both blebs showed low lying and
high vascularity (Fig. 1). No pupillary block was present. Mild
nuclear sclerosis was noted bilaterally. Gonioscopy demonstrated
two patent internal drainage clefts in his right eye. Full topical
antiglaucoma agents, intravenous Mannitol (20%), and anti-an. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Slit-lamp examination of his right eye revealed two blebs. The nasal upper bleb
had thinner wall with obvious focal underlying uvea dark color and temporal upper
bleb had a relatively thicker wall. Both blebs showed low lying and high vascularity.
Fig. 2. During a 6-month follow-up, the temporal upper bleb remained of a moderate
height without hypervascularity or cystic change.
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56 mm Hg to 16 mm Hg. The C/D ratio of the right eye was 80%.
However, the IOP reached 52 mm Hg 2 days later. After discussion
the risks and beneﬁts of further surgeries with the patient, needle
revision was then performed.
Because the nasal upper bleb had thinner wall with focal
underlying uvea dark color, we decided to leave it alone and did
needling only in the temporal upper bleb.
A mixture of lidocaine and MMC was prepared by drawing up
0.2 ml of 2% lidocaine and 0.1 ml of 0.2 mg/ml MMC solution into
the same insulin syringe, for a ﬁnal MMC concentration of
0.07 mg/ml. After peribulbar anesthesia, a lid speculumwas placed,
and the patient was asked to look down. The subconjunctival space
was entered approximately 7 mm away from bleb with a 27-gauge
needle, bent bevel up at the hub to an angle of 45 degrees. Only
0.1 ml of the lidocaine-MMC mixture (7 mg of MMC) was injected
and a gentle massage was applied to the superior eyelid for 5
minutes.
After 15 minutes following the lidocaine-MMC mixture injec-
tion, the cutting edges of the needle tip were used to disrupt any
episcleral ﬁbrosis with a sweeping motion and care was taken to
avoid perforation of the overlying tissues. When the initial
needling seemed to have little effect, deeper penetration was
attempted to disrupt scleral ﬁbrosis and to lift the scleral ﬂap.
Restoration of aqueous drainage was considered to be the end
point when the bleb height was restored. Because of the oblique
nature of needle entry, no suturing of the conjunctiva was
required.
The right eye VA was 20/100 on postoperatively Day 1 and IOP
was 8 mm Hg. The corneal was clear and the bleb height reap-
peared. The only minor complication was subconjunctival hemor-
rhage, which was absorbed 1 week later. The IOP was around
10e15 mm Hg without antiglaucoma agents during a 6-month
follow-up. The temporal upper bleb remained moderate height
without hypervascularity or cystic change (Fig. 2) and no corneal
edema was noted.
3. Discussion
Most previous studies have related effective needle revision to
Tenon’s cysts or encapsulated blebs alone.1,9 While some studies
have considered other speciﬁc types of bleb, either any nonen-
capsulated failed blebs5,6 or, even more speciﬁcally, ﬂat or ﬁbrotic
blebs.2 Our case demonstrated that needle revisionwith adjunctiveMMC could still restore aqueous drainage in a highly vascular and
ﬂat bleb.
Antimetabolite like MMC or 5-FU carries a higher likelihood of
successful needling.1e3,5e8 The modes of application of MMC
include topical usage before6 or after7 needle revision or sub-
conjunctival injection5,8 during needle revision. Most studies
reported subconjunctival injection of MMC had a good bleb
survival rate with different concentration of MMC from 0.08 to
0.2 mg/cc.5,8 The concentration of MMC in our case was
0.07 mg/cc, which was lighter comparing to previous studies.5,8
Higher concentration may enhance ﬁbrosis removal and reduce
repeat needling but there is always the concern of corneal
endothelial cell toxicity. Maestrini5 et al reported that corneal
endothelial cell density and hexagonality did not change signif-
icantly after needling with subconjunctival injection of MMC
(0.08 mg/cc), but their needling did not penetrate into AC. We
penetrated the AC like most other studies5,8 because we believed
high IOP before needling would have a positive pressure which
prevents the MMC ﬂow into AC. The 15 minutes waiting time
after initial injection of MMC from needling, along with ocular
massage, also reduced the risk of corneal toxicity. There is no
general guideline about the interval between MMC injection and
needle revision, mostly from immediately to 15 minutes.5,8,10,11
Because we did needle revision with scleral ﬂap lifting, we had
rather waited for a longer time (15 minutes) and fully massaged
subconjunctival MMC for diffusion to avoid local high concen-
tration and penetration into AC.
There is no consensus that interval between initial surgery and
needling makes any difference to the outcome. A short interval
between the initial surgery and needling has been associated with
success,12 although, in one report, an interval of more than 1
month was found to be advantageous.3 While other studies
concluded that the interval between initial surgery and needling
seem to make no difference to the outcome.2,4 As far as we know,
the interval between initial surgery and needling (more than 20
years) in this case is far more longer time than most previous
studies.2,5,6,8
Bleb needling has a number of advantages compared with redo
or repeat surgery. The procedure is simple and repeatable, and has
the potential to be equally effective as initial ﬁltration surgery. The
method is safe, carries no additional theoretical complications
over trabeculectomy, and does not preclude resorting to other
methods for IOP control if it fails because it preserves conjunctiva.
Thus, we suggest that bleb needling with adjunctive MMC should
P.-Y. Chang / Taiwan Journal of Ophthalmology 2 (2012) 103e105 105be considered in the management of failing or failed ﬁltration
blebs.
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